IL-6 delivers signals through the STAT3 pathway, and recent studies have reported that CD36 is a downstream target of activated STAT3, suggesting that upregulation of IL-6 expression would further increase the uptake of FAs by cancer cells (27, 28). This evidence concerns the gene STAT3 and cancer.